Altaeda Tablet
PDF Leaflet Revision Date: 22 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
Dosage (summary)
One tablet once daily, with or without food.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Coadministration with dofetilide, pilsicainide, metformin contraindicated
- Avoid with other tenofovir or emtricitabine-containing medicines
Contraindications
- Hypersensitivity to components
- Moderate or severe hepatic impairment
- Severe renal impairment (CrCl < 30 mL/min)
Common side effects
- Insomnia
- Fatigue
- Headache
- Nausea
Counselling Points
- Use reliable contraception to avoid pregnancy
- Monitor for signs of liver toxicity
- Regular follow-up for renal function
Serious warnings
- Hypersensitivity reactions
- Lactic acidosis
- Severe hepatotoxicity
- Immune reconstitution syndrome
Important Disclaimer
The Altaeda Tablet professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
